Your browser doesn't support javascript.
loading
Erratum to 'Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients': [ESMO Open Volume 7, Issue 1, February 2022, 100393].
Beechinor, R; Palumbo, A; Chew, H K; Arora, M.
Affiliation
  • Beechinor R; UC Davis Comprehensive Cancer Center, Sacramento; University of California, San Francisco School of Pharmacy, San Francisco. Electronic address: RBeechinor@ucdavis.edu.
  • Palumbo A; Department of Pharmacy, Oregon Health and Science University, Portland.
  • Chew HK; UC Davis Comprehensive Cancer Center, Sacramento; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA.
  • Arora M; UC Davis Comprehensive Cancer Center, Sacramento; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA.
ESMO Open ; 7(2): 100460, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35306439
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: Reino Unido